News Daily News Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients Michael O'Riordan February 25, 2022
News Conference News PCR London Valves 2021 Good Results but Small Numbers With JenaValve Trilogy in Severe AR Michael O'Riordan November 26, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Daily News Good TAVI Outcomes in Young Patients, but Population Is Unique Michael O'Riordan October 22, 2021
News Conference News ESC 2021 PET Imaging Detects Degeneration After TAVI as Well as Surgical, Native Valves Yael L. Maxwell September 02, 2021
News Daily News Big Downturn in CVD Procedures Seen During COVID-19’s First Wave Michael O'Riordan July 01, 2021
News Daily News AHA Advice for Rare but Deadly Mechanical Complications of Acute MI L.A. McKeown June 18, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Daily News New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research Michael O'Riordan April 23, 2021
News Daily News Unplanned PCI Rare After TAVI, but Operators Get Good Results Michael O'Riordan January 18, 2021
News Daily News Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut Michael O'Riordan October 28, 2020
News Daily News As Cardiac Procedures Plummet, Concerns Mount for COVID-19’s Collateral Damage Shelley Wood October 22, 2020
News Daily News Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves Michael O'Riordan May 27, 2020
News Daily News LV Mass Regression After TAVR Linked to Better Long-term Outcomes Michael O'Riordan May 13, 2020
News Daily News Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns Shelley Wood April 13, 2020
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Daily News MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR Michael O'Riordan February 13, 2020